Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer
Tumor cells can develop immune escape mechanisms to bypass T cell recognition, e.g., antigen loss or downregulation of the antigen presenting machinery, which represents a major challenge in adoptive T cell therapy. To counteract these mechanisms, we transferred not only one, but two receptors into...
Main Authors: | Bianca Simon, Dennis C. Harrer, Beatrice Schuler-Thurner, Gerold Schuler, Ugur Uslu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/696 |
Similar Items
-
A study on optimized lentiviral transduction conditions in CAR-T cells targeting CD30
by: TIAN Gaohui, ZHANG Qinxing, SHI Jiangzhou, ZHAO Fenfang, WANG Ning, ZHAO Jiaxuan, LU Yulin, XU Yao
Published: (2023-07-01) -
Identification of a small molecule for enhancing lentiviral transduction of T cells
by: Paulina Malach, et al.
Published: (2023-12-01) -
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
by: Karin Teppert, et al.
Published: (2023-10-01) -
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
by: Dennis Christoph Harrer, et al.
Published: (2022-10-01) -
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
by: Maren Soldierer, et al.
Published: (2022-04-01)